• STJ70055 (0. 3µg/ml) staining of Human Kidney lysate (35µg protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.
  • STJ70055 (0. 01µg/ml) staining of Daudi (A) and Molt4 (B) cell lysate (35µg protein in RIPA buffer). Primary incubation was 1 hour. Detected by chemiluminescence.

Anti-SET/I2 alpha PP2A antibody (N-Term) (STJ70055)

SKU:
STJ70055-100

Shipping:
Free Shipping
Current Stock:
Host: Goat
Applications: Pep-ELISA/WB/IHC
Reactivity: Human/Cow
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Goat polyclonal antibody anti-SET/I2 alpha PP2A (N-Term) is suitable for use in ELISA, Western Blot and Immunohistochemistry research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin. NA
Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Concentration: 0.5 mg/mL
Dilution Range: WB-0.3-1µg/ml
ELISA-antibody detection limit dilution 1:128000.
Storage Instruction: Store at-20°C on receipt and minimise freeze-thaw cycles.
Gene Symbol: SET
Gene ID: 6418
Uniprot ID: SET_HUMAN
Immunogen Region: N-Term
Accession Number: NP_003002.2
Specificity: This antibody is expected to recognize isoform 2 (NP_003002.2).
Immunogen Sequence: SAPAAKVSKKELNS
Post Translational Modifications Isoform 2 is phosphorylated on Ser-15 and Ser-24. Isoform 2 is acetylated on Lys-11. Some glutamate residues are glycylated by TTLL8. This modification occurs exclusively on glutamate residues and results in a glycine chain on the gamma-carboxyl group. N-terminus of isoform 1 is methylated by METTL11A/NTM1. Mainly trimethylated. Isoform 2: Cleaved after Lys-176 by GZMA. The cleavage inhibits its nucleosome assembly activity and disrupts the inhibition on NME1.
Function Multitasking protein, involved in apoptosis, transcription, nucleosome assembly and histone chaperoning. Isoform 2 anti-apoptotic activity is mediated by inhibition of the GZMA-activated DNase, NME1. In the course of cytotoxic T-lymphocyte (CTL)-induced apoptosis, GZMA cleaves SET, disrupting its binding to NME1 and releasing NME1 inhibition. Isoform 1 and isoform 2 are potent inhibitors of protein phosphatase 2A. Isoform 1 and isoform 2 inhibit EP300/CREBBP and PCAF-mediated acetylation of histones (HAT) and nucleosomes, most probably by masking the accessibility of lysines of histones to the acetylases. The predominant target for inhibition is histone H4. HAT inhibition leads to silencing of HAT-dependent transcription and prevents active demethylation of DNA. Both isoforms stimulate DNA replication of the adenovirus genome complexed with viral core proteins.however, isoform 2 specific activity is higher.
Protein Name Protein Set
Hla-Dr-Associated Protein Ii
Inhibitor Of Granzyme A-Activated Dnase
Igaad
Phapii
Phosphatase 2a Inhibitor I2pp2a
I-2pp2a
Template-Activating Factor I
Taf-I
Database Links Reactome: R-HSA-2299718
Reactome: R-HSA-450520
Cellular Localisation Cytoplasm
Cytosol
Endoplasmic Reticulum
Nucleus
Nucleoplasm
In The Cytoplasm
Found Both In The Cytosol And Associated With The Endoplasmic Reticulum
The Set Complex Is Associated With The Endoplasmic Reticulum
Following Ctl Attack And Cleavage By Gzma
Moves Rapidly To The Nucleus
Where It Is Found In The Nucleoplasm
Avoiding The Nucleolus
Similar Translocation To The Nucleus Is Also Observed For Lymphocyte-Activated Killer Cells After The Addition Of Calcium
Alternative Antibody Names Anti-Protein Set antibody
Anti-Hla-Dr-Associated Protein Ii antibody
Anti-Inhibitor Of Granzyme A-Activated Dnase antibody
Anti-Igaad antibody
Anti-Phapii antibody
Anti-Phosphatase 2a Inhibitor I2pp2a antibody
Anti-I-2pp2a antibody
Anti-Template-Activating Factor I antibody
Anti-Taf-I antibody
Anti-SET antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance